Back to Search Start Over

Will ABSORB III change my practice? Everolimus-eluting bioresorbable scaffolds for coronary artery disease.

Authors :
Cook S
Nef H
Capodanno D
Tamburino C
Baumbach A
Source :
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology [EuroIntervention] 2016 Aug 20; Vol. 12 (6), pp. 801-4.
Publication Year :
2016

Subjects

Subjects :
Antineoplastic Agents administration & dosage
Drug-Eluting Stents
Everolimus administration & dosage
Humans
Male
Middle Aged
Randomized Controlled Trials as Topic
Absorbable Implants
Blood Vessel Prosthesis Implantation
Coronary Artery Disease surgery
Tissue Scaffolds

Details

Language :
English
ISSN :
1969-6213
Volume :
12
Issue :
6
Database :
MEDLINE
Journal :
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Publication Type :
Report
Accession number :
27542795
Full Text :
https://doi.org/10.4244/EIJV12I6A130
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details